# Memantine and Down's Syndrome

> **NCT00240760** · NA · UNKNOWN · sponsor: **King's College London** · enrollment: 180 (—)

## Conditions studied

- Down's Syndrome
- Dementia
- Learning Disabilities

## Interventions

- **DRUG:** Memantine Hydrochloride

## Key facts

- **NCT ID:** NCT00240760
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 180 (—)
- **Last updated:** 2006-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240760, "Memantine and Down's Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00240760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*